首页> 外文OA文献 >Definition and classification of negative outcomes in solid organ transplantation. Application in liver transplantation.
【2h】

Definition and classification of negative outcomes in solid organ transplantation. Application in liver transplantation.

机译:实体器官移植阴性结果的定义和分类。在肝移植中的应用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVE: This study defined negative outcomes of solid organ transplantation, proposed a new classification of complications by severity, and applied the classification to evaluate the results of orthotopic liver transplantation (OLT). SUMMARY AND BACKGROUND DATA: The lack of uniform reporting of negative outcomes has made reports of transplantation procedures difficult to interpret and compare. In fact, only mortality is well reported; morbidity rates and severity of complications have been poorly described. METHODS: Based on previous definition and classification of complications for general surgery, a new classification for transplantation in four grades is proposed. Results including risk factors of the first 215 OLTs performed at the University of Toronto have been evaluated using the classification. RESULTS: All but two patients (99%) had at least one complication of any kind, 92% of patients surviving more than 3 months had grade 1 (minor) complications, 74% had grade 2 (life-threatening) complications, and 30% had grade 3 (residual disability or cancer) complications. Twenty-nine per cent of patients had grade 4 complications (retransplantation or death). The most common grade 1 complications were steroid responsive rejection (69% of patients) and infection that did not require antibiotics or invasive procedures (23%). Grade 2 complications primarily were infection requiring antibiotics or invasive procedures (64%), postoperative bleeding requiring > 3 units of packed red cells (35%), primary dysfunction (26%), and biliary disease treated with antibiotics or requiring invasive procedures (18%). The most frequent grade 3 complication was renal failure, which is defined as a permanent rise in serum creatinine levels > or = twice the pretransplantation values (11%). Grade 4 complications (retransplantation or death) mainly were infection (14%) and primary dysfunction (11%). Comparison between the first and last 50 OLTs of the series indicates a significant decrease in the mean number of grade 1 and 2 complications. This was partially a result of better medical status of patients at the time of transplantation. Using univariate and multivariate analyses of risk factors, the best predictor of grade 1 complications was donor obesity; for grade 2 complications, the best predictor was a donor liver rewarming time of > 90 minutes, and for grade 3 and 4 complications, the best predictor was the APACHE II scoring system and donor cardiac arrest. CONCLUSIONS: Standardized definitions and classifications of complications of transplantation will allow us to better evaluate and compare results of transplantation among centers and over time, and better compare effectiveness of new therapies. Orthotopic liver transplantation still is a procedure with high morbidity that requires careful analysis of risk factors to optimize selection of patients and organ sharing.
机译:目的:本研究定义了实体器官移植的阴性结果,提出了按严重程度分类的新并发症,并将该分类用于评估原位肝移植(OLT)的结果。总结和背景数据:缺乏统一的阴性结果报告使得移植程序的报告难以解释和比较。实际上,只有死亡率被充分报道。并发症的发病率和严重程度的描述很少。方法:基于常规外科手术并发症的定义和分类,提出了新的四级移植分类。使用分类评估了包括在多伦多大学进行的前215个OLT的风险因素在内的结果。结果:除两名患者外,其余所有患者(99%)均具有至少一种并发症,生存期超过3个月的患者中有92%患有1级(轻微)并发症,74%患有2级(危及生命)的并发症,其中30例%有3级(残障或癌症)并发症。 29%的患者患有4级并发症(再移植或死亡)。最常见的1级并发症是类固醇反应性排斥(占患者的69%)和不需要抗生素或侵入性手术的感染(占23%)。 2级并发症主要是需要抗生素或侵入性治疗的感染(64%),术后出血需要> 3个单位的红细胞堆积(35%),原发性功能障碍(26%)以及用抗生素治疗或需要侵入性治疗的胆道疾病(18) %)。最常见的3级并发症是肾衰竭,其定义为血清肌酐水平持续升高,≥或等于移植前值的两倍(11%)。 4级并发症(再移植或死亡)主要是感染(14%)和原发性功能障碍(11%)。比较该系列的第一个和最后一个50个OLT,可以明显降低1级和2级并发症的平均发生率。部分原因是移植时患者的医疗状况更好。使用危险因素的单因素和多因素分析,一级肥胖并发症的最佳预测指标是供体肥胖。对于2级并发症,最好的预测指标是供体肝脏复温时间> 90分钟,对于3级和4级并发症,最好的预测指标是APACHE II评分系统和供体心脏骤停。结论:标准化的移植并发症定义和分类将使我们能够更好地评估和比较各中心之间以及一段时间内的移植结果,并更好地比较新疗法的有效性。原位肝移植仍然是一种高发病率的手术,需要仔细分析危险因素以优化患者选择和器官共享。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号